全文获取类型
收费全文 | 48549篇 |
免费 | 3613篇 |
国内免费 | 159篇 |
专业分类
耳鼻咽喉 | 670篇 |
儿科学 | 1306篇 |
妇产科学 | 868篇 |
基础医学 | 6329篇 |
口腔科学 | 678篇 |
临床医学 | 5107篇 |
内科学 | 10155篇 |
皮肤病学 | 603篇 |
神经病学 | 4696篇 |
特种医学 | 1855篇 |
外科学 | 8001篇 |
综合类 | 917篇 |
现状与发展 | 1篇 |
一般理论 | 42篇 |
预防医学 | 3827篇 |
眼科学 | 617篇 |
药学 | 3272篇 |
中国医学 | 59篇 |
肿瘤学 | 3318篇 |
出版年
2023年 | 279篇 |
2022年 | 527篇 |
2021年 | 1214篇 |
2020年 | 689篇 |
2019年 | 1136篇 |
2018年 | 1345篇 |
2017年 | 911篇 |
2016年 | 1070篇 |
2015年 | 1287篇 |
2014年 | 1686篇 |
2013年 | 2238篇 |
2012年 | 3752篇 |
2011年 | 3819篇 |
2010年 | 2127篇 |
2009年 | 1915篇 |
2008年 | 3197篇 |
2007年 | 3270篇 |
2006年 | 3201篇 |
2005年 | 3239篇 |
2004年 | 2877篇 |
2003年 | 2735篇 |
2002年 | 2487篇 |
2001年 | 527篇 |
2000年 | 434篇 |
1999年 | 461篇 |
1998年 | 519篇 |
1997年 | 444篇 |
1996年 | 370篇 |
1995年 | 360篇 |
1994年 | 313篇 |
1993年 | 288篇 |
1992年 | 288篇 |
1991年 | 258篇 |
1990年 | 233篇 |
1989年 | 219篇 |
1988年 | 207篇 |
1987年 | 188篇 |
1986年 | 170篇 |
1985年 | 172篇 |
1984年 | 169篇 |
1983年 | 142篇 |
1982年 | 161篇 |
1981年 | 173篇 |
1980年 | 116篇 |
1979年 | 99篇 |
1978年 | 99篇 |
1977年 | 91篇 |
1976年 | 73篇 |
1975年 | 69篇 |
1973年 | 75篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Jasmohan S. Bajaj Jacqueline G. O’Leary Puneeta Tandon Florence Wong Patrick S. Kamath Scott W. Biggins Guadalupe Garcia-Tsao Jennifer Lai Michael B. Fallon Paul J. Thuluvath Hugo E. Vargas Benedict Maliakkal Ram M. Subramanian Leroy R. Thacker K. Rajender Reddy 《Clinical gastroenterology and hepatology》2021,19(3):565-572.e5
992.
Pilot study of intravenous melphalan combined with continuous infusion L‐S,R‐buthionine sulfoximine for children with recurrent neuroblastoma 下载免费PDF全文
993.
994.
995.
Ellis SG Popma JJ Lasala JM Koglin JJ Cox DA Hermiller J O'shaughnessy C Mann JT Turco M Caputo R Bergin P Greenberg J Stone GW 《Journal of the American College of Cardiology》2005,45(8):1193-1200
OBJECTIVES: We sought to evaluate the relationship between angiographic late loss and clinical outcomes in the drug-eluting stent era. BACKGROUND: The interrelationship between angiographic late loss, binary restenosis, and clinical recurrence (target lesion revascularization [TLR]) after coronary stent implantation has been incompletely evaluated. METHODS: Using the angiographic substudy of the TAXUS-IV trial, in which 1,314 patients with de novo coronary lesions were randomized to either the paclitaxel-eluting TAXUS stent or to its bare-metal equivalent, we defined the relationship between in-stent and analysis segment late loss, the shape of the late loss histogram (variance and skewedness), and nine-month TLR. RESULTS: Late loss by several measures was closely related to TLR (area under the receiver-operator curve >0.90). For individual vessels of the size in this study (2.8 +/- 0.5 mm), the likelihood of TLR did not exceed 5% until analysis segment late loss was >0.5 mm, and did not exceed 10% until late loss was >0.65 mm. At greater late losses, the late loss TLR relationship was steep and nearly linear. For the overall patient cohort, the rate of TLR was related, however, not only to median late loss, but also to measures of its statistical distribution (TLR increased with lack of homogeneous biologic response [greater variance and greater right skewedness]). Similar relationships held for late loss measured within the confines of the stent itself. CONCLUSIONS: Coronary stents result in large lumens with "room" to accommodate up to approximately 0.5 to 0.65 mm of tissue (angiographic analysis segment late loss) before the likelihood of clinical restenosis (TLR) exceeds 5% to 10%. These data have important implications toward understanding the absolute and relative efficacy of drug-eluting stents. 相似文献
996.
Lundberg K Kinloch A Fisher BA Wegner N Wait R Charles P Mikuls TR Venables PJ 《Arthritis and rheumatism》2008,58(10):3009-3019
OBJECTIVE: To map the antibody response to human citrullinated alpha-enolase, a candidate autoantigen in rheumatoid arthritis (RA), and to examine cross-reactivity with bacterial enolase. METHODS: Serum samples obtained from patients with RA, disease control subjects, and healthy control subjects were tested by enzyme-linked immunosorbent assay (ELISA) for reactivity with citrullinated alpha-enolase peptides. Antibodies specific for the immunodominant epitope were raised in rabbits or were purified from RA sera. Cross-reactivity with other citrullinated epitopes was investigated by inhibition ELISAs, and cross-reactivity with bacterial enolase was investigated by immunoblotting. RESULTS: An immunodominant peptide, citrullinated alpha-enolase peptide 1, was identified. Antibodies to this epitope were observed in 37-62% of sera obtained from patients with RA, 3% of sera obtained from disease control subjects, and 2% of sera obtained from healthy control subjects. Binding was inhibited with homologous peptide but not with the arginine-containing control peptide or with 4 citrullinated peptides from elsewhere on the molecule, indicating that antibody binding was dependent on both citrulline and flanking amino acids. The immunodominant peptide showed 82% homology with enolase from Porphyromonas gingivalis, and the levels of antibodies to citrullinated alpha-enolase peptide 1 correlated with the levels of antibodies to the bacterial peptide (r2=0.803, P<0.0001). Affinity-purified antibodies to the human peptide cross-reacted with citrullinated recombinant P gingivalis enolase. CONCLUSION: We have identified an immunodominant epitope in citrullinated alpha-enolase, to which antibodies are specific for RA. Our data on sequence similarity and cross-reactivity with bacterial enolase may indicate a role for bacterial infection, particularly with P gingivalis, in priming autoimmunity in a subset of patients with RA. 相似文献
997.
Manckoundia P Buatois S Gueguen R Perret-Guillaume C Laurain MC Pfitzenmeyer P Benetos A 《Archives of gerontology and geriatrics》2008,47(2):217-228
We assessed the role of clinical and biological parameters on performance in four balance tests in elderly subjects. An observational study was conducted in the Center for Preventive Medicine of Nancy (France) in 2368 community-living elderly subjects aged 60 and older. Body mass index (BMI), Mini-Mental State Examination (MMSE), clock test, “Health score” and use of psychotropic drugs (UPD) were assessed. Participants performed four balance tests: “one-leg-stand” (OLS), “timed-up-and-go” (TUG), “rise-from-the-floor” (RFF) and “sit-to-stand” (STS). The statistical analysis showed that women were almost twice as likely to fail balance tests as men. In both women and men, the following determinant factors of the performance in balance tests were found: for OLS: age, BMI and health score; for TUG: age, BMI, clock test and health score; for RFF: BMI and health score. In addition, in women other determinant factors were: MMSE for OLS, UPD for TUG, age and clock test for RFF. In men, the clock test and the UPD were also significant determinant factors for OLS. Similar results were found for STS. In conclusion, female sex, overweight, low cognitive status, low self-perception of health and UPD were associated with a higher risk of failure in balance tests. 相似文献
998.
Grime JM Edwards MA Rudd NC Unwin PR 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(38):14277-14282
The ability to predict and interpret membrane permeation coefficients is of critical importance, particularly because passive transport is crucial for the effective delivery of many pharmaceutical agents to intracellular targets. We present a method for the quantitative measurement of the permeation coefficients of protonophores by using laser confocal scanning microscopy coupled to microelectrochemistry, which is amenable to precise modeling with the finite element method. The technique delivers well defined and high mass transport rates and allows rapid visualization of the entire pH distribution on both the cis and trans side of model bilayer lipid membranes (BLMs). A homologous series of carboxylic acids was investigated as probe molecules for BLMs composed of soybean phosphatidylcholine. Significantly, the permeation coefficient decreased with acyl tail length contrary to previous work and to Overton's rule. The reasons for this difference are considered, and we suggest that the applicability of Overton's rule requires re-evaluation. 相似文献
999.
Aoki J Serruys PW van Beusekom H Ong AT McFadden EP Sianos G van der Giessen WJ Regar E de Feyter PJ Davis HR Rowland S Kutryk MJ 《Journal of the American College of Cardiology》2005,45(10):1574-1579
OBJECTIVES: This study was designed to evaluate whether rapid endothelialization of stainless steel stents with a functional endothelium prevents stent thrombosis and reduces the restenotic process. BACKGROUND: A "pro-healing" approach for prevention of post-stenting restenosis is theoretically favored over the use of cytotoxic or cytostatic local pharmacologic therapies. It is believed that the central role of the vascular endothelium is to maintain quiescence of the underlying media and adventitia. METHODS: Sixteen patients with de novo coronary artery disease were successfully treated with implantation of endothelial progenitor cell (EPC) capture stents. RESULTS: Complete procedural and angiographic success was achieved in all 16 patients. The nine-month composite major adverse cardiac and cerebrovascular events (MACCE) rate was 6.3% as a result of a symptom-driven target vessel revascularization in a single patient. There were no other MACCE despite only one month of clopidogrel treatment. At six-month follow-up, mean angiographic late luminal loss was 0.63 +/- 0.52 mm, and percent stent volume obstruction by intravascular ultrasound analysis was 27.2 +/- 20.9%. CONCLUSIONS: This first human clinical investigation of this technology demonstrates that the EPC capture coronary stent is safe and feasible for the treatment of de novo coronary artery disease. Further developments in this technology are warranted to evaluate the efficacy of this device for the treatment of coronary artery disease. 相似文献
1000.
Sulé Gunter Chanel Robinson Gavin R. Norton Angela J. Woodiwiss Linda Tsang Aletta M. E. Millen Patrick H. Dessein 《Clinical rheumatology》2018,37(6):1481-1491
Apelin can improve arterial function by enhancing the expression of endothelial nitric oxide synthase but this effect depends markedly on endothelial integrity. We hypothesized that inflammation influences the potential impact of apelin on arterial function in rheumatoid arthritis (RA). We assessed the associations of apelin concentrations with arterial stiffness (pulse wave velocity), wave reflection (augmentation index, reflected wave pressure, and reflection magnitude), and pressure pulsatility (central systolic pressure (CSP), central pulse pressure (CPP), peripheral pulse pressure (PPP), pulse pressure amplification (PPamp), and forward wave pressure (Pf)) among 170 RA patients without cardiovascular disease. In multivariable regression models, apelin concentrations were not independently associated with arterial function measures (p?≥?0.15) in all patients. Inflammation markers were not consistently associated with apelin levels but joint deformity counts, Disease Activity Score in 28 joints (DAS28), and erythrocyte sedimentation rate (ESR) impacted apelin-pressure pulsatility relations (interaction p?≤?0.05). In stratified analysis, apelin was associated with CSP (partial r?=???0.33, p?=?0.01), CPP (partial r?=???0.26, p?=?0.04), PPamp (partial r?=?0.27, p?=?0.03), and Pf (partial r?=???0.33, p?=?0.01) in patients without but not with joint deformities; apelin was related to CSP (partial r?=???0.24, p?=?0.05) in those with a DAS28 joint <?2.8 (median value) (partial r?=???0.24, p?=?0.05) but not ≥?2.8, and to CSP (partial r?=???0.36, p?=?0.003) in those with an erythrocyte sedimentation rate <?13 mm/h (median value) but not ≥?13 mm/h. Apelin is associated with reduced pressure pulsatility in RA patients without but not with a high inflammatory burden. A loss of apelin protective effects on arterial function may contribute to the link between RA severity and cardiovascular risk. 相似文献